| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| X Henry Hu, Scott A Bull, Enid M Hunkeler, Eileen Ming, Janelle Y Lee, Bruce Fireman, Leona E Markso. Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: patient report versus physician estimate. The Journal of clinical psychiatry. vol 65. issue 7. 2004-09-13. PMID:15291685. |
selective serotonin reuptake inhibitors (ssris) are widely used as the first-line treatment for depression. |
2004-09-13 |
2023-08-12 |
Not clear |
| Suchet D Khanzode, Ganesh N Dakhale, Shruti S Khanzode, Anand Saoji, R Palasodka. Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors. Redox report : communications in free radical research. vol 8. issue 6. 2004-09-09. PMID:14980069. |
oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors. |
2004-09-09 |
2023-08-12 |
human |
| Pablo V Escribá, Andrés Ozaita, Jesús A García-Sevill. Increased mRNA expression of alpha2A-adrenoceptors, serotonin receptors and mu-opioid receptors in the brains of suicide victims. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 29. issue 8. 2004-09-08. PMID:15199368. |
alterations in adrenoceptors, serotonin receptors, and other g protein-coupled receptors (gpcrs) have been associated with suicide and depression. |
2004-09-08 |
2023-08-12 |
human |
| Jack R Cornelius, Duncan B Clark, Ihsan M Salloum, Oscar G Bukstein, Thomas M Kell. Interventions in suicidal alcoholics. Alcoholism, clinical and experimental research. vol 28. issue 5 Suppl. 2004-09-07. PMID:15166640. |
the state of the art is reviewed regarding interventions, including acute stabilization and specific medications for alcoholism and depression with a special focus on the selective serotonin reuptake inhibitors. |
2004-09-07 |
2023-08-12 |
Not clear |
| Katharina Schröcksnadel, Bernhard Widner, Anton Bergant, Gabriele Neurauter, Hans Schröcksnadel, Dietmar Fuch. Tryptophan degradation during and after gestation. Advances in experimental medicine and biology. vol 527. 2004-09-02. PMID:15206718. |
on the other hand, postpartum blues and depression appear to be related to reduced availability of tryptophan and serotonin. |
2004-09-02 |
2023-08-12 |
mouse |
| François Curtin, Pierre Schul. Use of selective serotonin reuptake inhibitors in childhood depression. Lancet (London, England). vol 364. issue 9435. 2004-09-02. PMID:15325821. |
use of selective serotonin reuptake inhibitors in childhood depression. |
2004-09-02 |
2023-08-12 |
Not clear |
| Alen J Saleria. Use of selective serotonin reuptake inhibitors in childhood depression. Lancet (London, England). vol 364. issue 9435. 2004-09-02. PMID:15325822. |
use of selective serotonin reuptake inhibitors in childhood depression. |
2004-09-02 |
2023-08-12 |
Not clear |
| Tamar Wohlfarth, Frits Lekkerkerker, Barbara van Zwiete. Use of selective serotonin reuptake inhibitors in childhood depression. Lancet (London, England). vol 364. issue 9435. 2004-09-02. PMID:15325820. |
use of selective serotonin reuptake inhibitors in childhood depression. |
2004-09-02 |
2023-08-12 |
Not clear |
| William H Theodor. Epilepsy and depression: imaging potential common factors. Clinical EEG and neuroscience. vol 35. issue 1. 2004-08-26. PMID:15112462. |
neuroimaging studies, including structural magnetic resonance imaging, positron emission tomography measurements of cerebral glucose metabolism, and, more recently, imaging of serotonin 1a receptors, may provide additional data to explain overlapping clinical manifestations of epilepsy and depression. |
2004-08-26 |
2023-08-12 |
Not clear |
| Elisabeth Maurer-Spurej, Cheryl Pittendreigh, Kevin Solomon. The influence of selective serotonin reuptake inhibitors on human platelet serotonin. Thrombosis and haemostasis. vol 91. issue 1. 2004-08-24. PMID:14691577. |
the goal of this pilot study was to measure the 5-ht levels in platelets of untreated and ssri-treated depressed patients and normal subjects and to determine whether the interaction of ssris with platelets can explain their possible cardiovascular benefit in patients with depression. |
2004-08-24 |
2023-08-12 |
human |
| Elisabeth Maurer-Spurej, Cheryl Pittendreigh, Kevin Solomon. The influence of selective serotonin reuptake inhibitors on human platelet serotonin. Thrombosis and haemostasis. vol 91. issue 1. 2004-08-24. PMID:14691577. |
depression caused a significant reduction in platelet 5-ht to 46 +/- 21% in untreated patients (n = 13) and 22 +/- 13% in ssri-treated patients (n = 14). |
2004-08-24 |
2023-08-12 |
human |
| Catherine J Harmer, Nicholas C Shelley, Philip J Cowen, Guy M Goodwi. Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. The American journal of psychiatry. vol 161. issue 7. 2004-08-19. PMID:15229059. |
antidepressants that inhibit the reuptake of serotonin (ssris) or norepinephrine (snris) are effective in the treatment of disorders such as depression and anxiety. |
2004-08-19 |
2023-08-12 |
human |
| David Cohen, Priscille Gerardin, Philippe Mazet, Diane Purper-Ouakil, Martine F Flamen. Pharmacological treatment of adolescent major depression. Journal of child and adolescent psychopharmacology. vol 14. issue 1. 2004-08-17. PMID:15142388. |
is there a serotonin hypothesis for juvenile depression? |
2004-08-17 |
2023-08-12 |
Not clear |
| Motoko Honda, Mitsuo Tanabe, Hideki On. Serotonergic depression of spinal monosynaptic transmission is mediated by 5-HT1B receptors. European journal of pharmacology. vol 482. issue 1-3. 2004-08-16. PMID:14660017. |
3-hydroxybenzylhydrazine dihydrochloride (nsd-1015), a centrally active decarboxylase inhibitor, abolished this inhibition, confirming that the depression of the monosynaptic reflex by l-5-hydroxytryptophan was due to 5-ht. |
2004-08-16 |
2023-08-12 |
rat |
| Motoko Honda, Mitsuo Tanabe, Hideki On. Serotonergic depression of spinal monosynaptic transmission is mediated by 5-HT1B receptors. European journal of pharmacology. vol 482. issue 1-3. 2004-08-16. PMID:14660017. |
these results suggest that serotonergic depression of monosynaptic reflex transmission is mediated by 5-ht(1b) receptors. |
2004-08-16 |
2023-08-12 |
rat |
| Takeshi Inoue, Takeshi Izumi, Xiao-Bai Li, Ji Zhong Huang, Yuji Kitaichi, Shin Nakagawa, Tsukasa Koyam. [Biological basis of anxiety disorders and serotonergic anxiolytics]. Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology. vol 24. issue 3. 2004-08-16. PMID:15291241. |
selective serotonin reuptake inhibitors (ssris) have wide indications for the treatment of anxiety disorders, including panic disorder, generalized anxiety disorder, posttraumatic stress disorder, obsessive-compulsive disorder and social anxiety disorder in addition to depression. |
2004-08-16 |
2023-08-12 |
Not clear |
| Liborio Rampello, Santina Chiechio, Giovanni Nicoletti, Alessandro Alvano, Ignazio Vecchio, Rocco Raffaele, Mariano Malaguarner. Prediction of the response to citalopram and reboxetine in post-stroke depressed patients. Psychopharmacology. vol 173. issue 1-2. 2004-08-06. PMID:14685645. |
here we investigate the efficacy and safety of a selective serotonin reuptake inhibitor (ssri), citalopram, and a noradrenaline reuptake inhibitor (nari), reboxetine, in post-stroke patients affected by anxious depression or retarded depression. |
2004-08-06 |
2023-08-12 |
Not clear |
| Sandra Lee, John R Walker, Laura Jakul, Kathryn Sexto. Does elimination of placebo responders in a placebo run-in increase the treatment effect in randomized clinical trials? A meta-analytic evaluation. Depression and anxiety. vol 19. issue 1. 2004-08-02. PMID:14978780. |
we compared the effect size of randomized, placebo-controlled clinical trials (in the treatment of depression with selective serotonin reuptake inhibitors [ssris]) that include a placebo run-in phase with those that do not, using a meta-analytic approach. |
2004-08-02 |
2023-08-12 |
human |
| b' S Kasper, J P Oli\\xc3\\xa. A meta-analysis of randomized controlled trials of tianeptine versus SSRI in the short-term treatment of depression. European psychiatry : the journal of the Association of European Psychiatrists. vol 17 Suppl 3. 2004-07-29. PMID:15177089.' |
a meta-analysis was performed to compare the efficacy of tianeptine and selective serotonin reuptake inhibitors (ssri) in the short-term treatment of depression. |
2004-07-29 |
2023-08-12 |
human |
| E Pretoriu. Corticosteroids, depression and the role of serotonin. Reviews in the neurosciences. vol 15. issue 2. 2004-07-28. PMID:15202683. |
corticosteroids, depression and the role of serotonin. |
2004-07-28 |
2023-08-12 |
Not clear |